在神经退行性疾病中 TDP-43 错误折叠的形状
Meenakshi Pillai1,2, Santosh Kumar Jha1,2
1Physical and Materials Chemistry Division, CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411008, India.
ACS omega
|October 7, 2024
概括
蛋白质错误折叠和聚合是神经退行症的关键. 本综述探讨了TDP-43中的构造变化,特别是其RRM域,如何推动ALS和FTLD等疾病的聚合,并提出了诊断和治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 蛋白质错误折叠和聚合是神经退行性疾病的标志.
- TDP-43蛋白质错误折叠与肌缩侧面硬化症 (ALS) 和前叶退化症 (FTLD) 有关.
- 在疾病条件下,TDP-43表现出多样化的形状和寡合状态.
研究的目的:
- 调查TDP-43蛋白质的结构变异性及其聚合倾向之间的关系.
- 专注于RRM域在TDP-43形状变化和聚合中的作用.
- 探索针对TDP-43形态的潜在诊断和治疗策略.
主要方法:
- 对TDP-43蛋白质结构和聚合的现有文献的审查.
- 分析详细介绍TDP-43形状动态的研究,特别是RRM领域.
- 综合有关疾病机制和潜在治疗干预措施的信息.
主要成果:
- 特别是在RRM领域内,TDP-43的形状变异性与其聚合密切相关.
- 提出了特定的蛋白质构造来驱动聚合过程.
- 了解这些构造状态可以让我们深入了解疾病的发病性.
结论:
- TDP-43的形状可塑性是其聚合和相关的神经退行的一个关键因素.
- 针对特定的TDP-43形状可能为ALS和FTLD提供新的诊断和治疗策略.
- 对TDP-43的结构动态进行进一步的研究对于开发有效的治疗方法至关重要.
更多相关视频
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.8K
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
596
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Protein Folding
7.8K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
7.8K
Intrinsically Disordered Proteins
17.7K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
17.7K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
